Literature DB >> 12351222

Genetic diversity and models of viral evolution for the hepatitis C virus.

M P H Stumpf1, O G Pybus.   

Abstract

In this review we discuss the application of theoretical frameworks to the interpretation of viral gene sequence data, with particular reference to the hepatitis C virus (HCV). The increasing availability of such data means that it is now possible (and necessary) to proceed from simple qualitative models of viral evolution, to more quantitative frameworks based on statistical inference, notably population genetics and molecular phylogenetics. We argue that these approaches are invaluable tools to the virologist and are essential for understanding the dynamics of viral infection and the outcome of therapeutic strategies. We use several recent HCV data-sets to illustrate the methods.

Entities:  

Mesh:

Year:  2002        PMID: 12351222     DOI: 10.1111/j.1574-6968.2002.tb11338.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  23 in total

1.  Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Authors:  Harel Dahari; Stephen M Feinstone; Marian E Major
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

2.  Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.

Authors:  Suwanna Noppornpanth; Truong Xuan Lien; Yong Poovorawan; Saskia L Smits; Albert D M E Osterhaus; Bart L Haagmans
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Phylogenetic analysis of previously nontypeable hepatitis C virus isolates from Argentina.

Authors:  María Inés Gismondi; Pablo Daniel Becker; Pamela Valva; Carlos Alberto Guzmán; María Victoria Preciado
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 4.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

5.  Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases.

Authors:  Hurng-Yi Wang; Ming-Hung Chien; Hsiang-Po Huang; Hsiao-Chi Chang; Chung-Che Wu; Pei-Jer Chen; Mei-Hwei Chang; Ding-Shinn Chen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

6.  High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression.

Authors:  Isabelle Sheridan; Oliver G Pybus; Edward C Holmes; Paul Klenerman
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  CD81 is an entry coreceptor for hepatitis C virus.

Authors:  Emmanuel G Cormier; Fay Tsamis; Francis Kajumo; Robert J Durso; Jason P Gardner; Tatjana Dragic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

Review 8.  Status of hepatitis C virus vaccination: Recent update.

Authors:  Kouka Saadeldin Abdelwahab; Zeinab Nabil Ahmed Said
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 9.  Drug Abuse, HIV, and HCV in Asian Countries.

Authors:  Yih-Ing Hser; Di Liang; Yu-Ching Lan; Balasingam Kasinather Vicknasingam; Amit Chakrabarti
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-21       Impact factor: 4.147

10.  The evolutionary dynamics of a rapidly mutating virus within and between hosts: the case of hepatitis C virus.

Authors:  Fabio Luciani; Samuel Alizon
Journal:  PLoS Comput Biol       Date:  2009-11-13       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.